Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		9 Months Ended
		Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Net Sales		$ 71,010	$ 72,832	$ 242,088	$ 247,330
Cost of products and services sold		54,834	57,180	183,558	190,207
Restructuring costs		223	261	758	792
Severance costs		11	54	11	77
Gross profit		15,942	15,337	57,761	56,254
Selling and administrative expenses		17,032	17,515	55,045	54,990
Restructuring (gain) costs		(3,729)	107	(8,576)	132
Severance costs		8	(12)	62	457
Impairment of goodwill					20,165
Transition and realignment costs					120
Operating income (loss)		2,631	(2,273)	11,230	(19,610)
Interest (income)		(1)	(6)	(3)	(37)
Interest expense		129	585	795	1,749
Other expense		642	183	633	183
Income (loss) before income taxes		1,861	(3,035)	9,805	(21,505)
Income tax expense (benefit)			133	1,726	(4,304)
Net income (loss)		$ 1,861	$ (3,168)	$ 8,079	$ (17,201)
Earnings (loss) per common share (see Note 4)
Basic (in dollars per share)		$ 0.07	$ (0.12)	$ 0.31	$ (0.66)
Diluted (in dollars per share)		$ 0.07	$ (0.12)	$ 0.31	$ (0.66)
Weighted average common shares outstanding
Basic (in shares)		26,301	26,132	26,250	26,083
Diluted (in shares)	[1]	26,623	26,132	26,423	26,083

[1] Calculated using the Treasury Stock method as if dilutive securities were exercised and the funds were used to purchase common shares at the average market price during the period.